Castro Domínguez Francisco
Stem cells are undifferentiated cells with the ability to self-renew and differentiate into different specialized cell types in the body. They have the unique ability to generate daughter cells identical to themselves (self-renewal) and also to become different types of cells in the body (differentiation).
There are different types of stem cells that have been studied in relation to osteoarthritis. These include:
Mesenchymal stem cells (MSCs):
Mesenchymal stem cells are a type of adult stem cells found in various tissues, such as bone marrow, adipose tissue, and cartilage.
MSCs have the ability to differentiate into cartilage cells and also possess anti-inflammatory and regenerative properties.
In the treatment of osteoarthritis, MSCs have been used to stimulate the regeneration of damaged cartilage and reduce inflammation in affected joints.
Hematopoietic stem cells (HSC):
Hematopoietic stem cells are found in the bone marrow and are responsible for generating blood cells in the body.
In addition to their role in blood cell production, HSCs also have anti-inflammatory properties and immune system modulating capabilities.
In osteoarthritis, HSCs have been investigated as a therapeutic option to reduce inflammation and promote cartilage regeneration.
Induced Pluripotent Stem Cells (iPSCs):
Induced pluripotent stem cells are adult cells genetically reprogrammed to acquire similar characteristics to embryonic stem cells.
iPSCs have the ability to differentiate into any type of cell in the body, including cartilage cells.
In osteoarthritis research, iPSCs have been used to generate cartilage cells that can be used in the regeneration and repair of damaged cartilage.
In relation to osteoarthritis, stem cells have been investigated as a promising therapeutic option to regenerate cartilage and improve joint function. Research and clinical trials are ongoing to assess the safety and efficacy of these therapies in the treatment of osteoarthritis. However, it is important to note that more research is still required before these therapies become widely available in clinical practice.
Morning | Afternoon | |
---|---|---|
Monday | 09:00 - 14:00 h | 14:30 - 19:00 h |
Tuesday | 09:00 - 14:00 h | 14:30 - 19:00 h |
Wednesday | 09:00 - 14:00 h | 14:30 - 19:00 h |
Thursday | 09:00 - 14:00 h | 14:30 - 19:00 h |
Friday | 09:00 - 14:00 h | 14:30 - 19:00 h |